Factores asociados a la vacunación frente a mpox en personas en profilaxis preexposición frente al VIH en la Comunidad de Madrid

IF 2.5 4区医学 Q3 INFECTIOUS DISEASES

Enfermedades infecciosas y microbiologia clinica Pub Date : 2025-06-01 DOI:10.1016/j.eimc.2024.10.008

M. Angeles Gutiérrez Rodríguez , Cristina Rodríguez Luque , Amaya Sánchez Gómez , M. Dolores Lasheras Carbajo , Soledad Cañellas Llabrés , Beatriz Lopez Centeno , Diego Morales Irala , María C. Vázquez Torres , Marta Molina Olivas

{"title":"Factores asociados a la vacunación frente a mpox en personas en profilaxis preexposición frente al VIH en la Comunidad de Madrid","authors":"M. Angeles Gutiérrez Rodríguez , Cristina Rodríguez Luque , Amaya Sánchez Gómez , M. Dolores Lasheras Carbajo , Soledad Cañellas Llabrés , Beatriz Lopez Centeno , Diego Morales Irala , María C. Vázquez Torres , Marta Molina Olivas","doi":"10.1016/j.eimc.2024.10.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>In May 2022, a mpox outbreak was identified in Europe. The majority of those affected are young men with risky sexual relations. In Spain, to control the outbreak, vaccination is recommended, among others, for people on HIV pre-exposure prophylaxis (PrEP). The objective of the study is to determine the factors associated with vaccination against mpox in people included in PrEP in the Community of Madrid.</div></div><div><h3>Methods</h3><div>Descriptive study. The sources of information used are: the PrEP registry, health card, the vaccine registry and the primary care clinical history. The 2011 deprivation index of the Spanish Society of Epidemiology is used as a socioeconomic indicator. Factors related to vaccination against mpox are analyzed and a conditional logistic regression model is fitted.</div></div><div><h3>Results</h3><div>A total of 6690 people were registered for PrEP. The average age was 37.7 years, 98.8% were men and 25.1% were foreigners. A percentage of 39.9 had received vaccination against mpox, 47.6% against hepatitis A, 32.8% against hepatitis B, 53.3% against COVID-19 and 24.3% against influenza. The variables associated with mpox vaccination were age, country of birth, influenza vaccination, hepatitis A vaccination, COVID-19 vaccination, and deprivation index.</div></div><div><h3>Conclusion</h3><div>Men who had sex with men, young adults, born in Spain, with a history of vaccination against influenza, hepatitis A and COVID-19 have a greater probability of vaccination against mpox. The proportion of vaccinated subjects decreases as the deprivation index increases.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"43 6","pages":"Pages 317-322"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24003343","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction

In May 2022, a mpox outbreak was identified in Europe. The majority of those affected are young men with risky sexual relations. In Spain, to control the outbreak, vaccination is recommended, among others, for people on HIV pre-exposure prophylaxis (PrEP). The objective of the study is to determine the factors associated with vaccination against mpox in people included in PrEP in the Community of Madrid.

Methods

Descriptive study. The sources of information used are: the PrEP registry, health card, the vaccine registry and the primary care clinical history. The 2011 deprivation index of the Spanish Society of Epidemiology is used as a socioeconomic indicator. Factors related to vaccination against mpox are analyzed and a conditional logistic regression model is fitted.

Results

A total of 6690 people were registered for PrEP. The average age was 37.7 years, 98.8% were men and 25.1% were foreigners. A percentage of 39.9 had received vaccination against mpox, 47.6% against hepatitis A, 32.8% against hepatitis B, 53.3% against COVID-19 and 24.3% against influenza. The variables associated with mpox vaccination were age, country of birth, influenza vaccination, hepatitis A vaccination, COVID-19 vaccination, and deprivation index.

Conclusion

Men who had sex with men, young adults, born in Spain, with a history of vaccination against influenza, hepatitis A and COVID-19 have a greater probability of vaccination against mpox. The proportion of vaccinated subjects decreases as the deprivation index increases.

查看原文本刊更多论文

在马德里社区进行艾滋病毒接触前预防的人群中，与Mpox疫苗接种相关的因素

2022年5月，欧洲发现了一次痘疫情。受影响的大多数是有危险性关系的年轻男子。在西班牙，为了控制疫情，除其他外，建议对接受艾滋病毒暴露前预防（PrEP）的人进行疫苗接种。本研究的目的是确定马德里社区PrEP人群中与接种m痘疫苗相关的因素。MethodsDescriptive研究。所使用的信息来源是：预防PrEP登记、保健卡、疫苗登记和初级保健临床病史。2011年西班牙流行病学学会的剥夺指数被用作社会经济指标。分析了接种m痘疫苗的相关因素，并拟合了条件logistic回归模型。结果共有6690人登记参加PrEP，平均年龄37.7岁，其中男性占98.8%，外国人占25.1%。接种麻疹疫苗的比例为39.9%，接种甲型肝炎疫苗的比例为47.6%，接种乙型肝炎疫苗的比例为32.8%，接种COVID-19疫苗的比例为53.3%，接种流感疫苗的比例为24.3%。与m痘疫苗接种相关的变量为年龄、出生国家、流感疫苗接种、甲型肝炎疫苗接种、COVID-19疫苗接种和剥夺指数。结论西班牙出生的男男性行为者、青壮年、有流感、甲型肝炎和COVID-19疫苗接种史的男性接种m痘疫苗的可能性较大。接种疫苗的比例随着剥夺指数的增加而降低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Enfermedades infecciosas y microbiologia clinica 医学-传染病学

CiteScore

2.10

自引率

8.00%

发文量

194

审稿时长

29 days

期刊介绍： Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.